Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | PRKDC | P78527 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | FYN | P06241 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7746122 | 0.89 | LMNA (0.45) | GAAMAPT | |
| SCHEMBL7746175 | 0.89 | LMNA (0.45) | GAAMAPT | |
| SCHEMBL5582119 | 0.84 | P2RX3 (0.35) | GAAPOLBL3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL7297079 | 0.82 | LMNA (0.49) | POLBL3MBTL1CYP3A4MAPT | |
| SCHEMBL7281047 | 0.80 | CYP1A2 (0.46) | GAAPRKDCPOLBL3MBTL1LCK | |
| SCHEMBL7383152 | 0.80 | MEN1 (0.50) | L3MBTL1MAPT | |
| Ammonia Solution, Strong SCHEMBL27836692 | 0.78 | CYP1A2 (0.45) | GAAPRKDCPOLBL3MBTL1LCK | |
| SCHEMBL27795531 | 0.78 | CYP1A2 (0.45) | GAAPRKDCPOLBL3MBTL1LCK | |
| SCHEMBL27937247 | 0.77 | LCK (0.47) | GAAPRKDCLCKFYNCYP1A2 | |
| SCHEMBL24456201 | 0.77 | GAA (0.48) | GAAPRKDCPOLBL3MBTL1LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2868659-B1 | Method for producing optically active naphthalene compound | MITSUBISHI TANABE PHARMA CORP (JP) | 2016-05-04 | — | — | EP | disclosed |
| EP-1964925-B1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE 4-HYDROXY-1,2,3,4 -TETRAHYDROQUINOLINES | MITSUBISHI TANABE PHARMA CORP (JP) | 2016-03-30 | — | — | EP | disclosed |
| US-9181217-B2 | Method for producing optically active naphthalene compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-11-10 | — | — | US | disclosed |
| US-20150152082-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-06-04 | — | — | US | disclosed |
| EP-2749558-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | Mitsubishi Tanabe Pharma Corporation (JP) | 2014-07-02 | — | — | EP | disclosed |
| US-8754221-B2 | Optically active cyclic alcohol compound and method for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2014-06-17 | — | — | US | disclosed |
| US-20130237708-A1 | Optically Active Cyclic Alcohol Compound And Method For Preparing The Same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2013-09-12 | — | — | US | disclosed |
| EP-2371820-B1 | Optically active cyclic alcohol compound and method for preparing the same | MITSUBISHI TANABE PHARMA CORP (JP) | 2013-08-28 | — | — | EP | disclosed |
| US-8471028-B2 | Optically active cyclic alcohol compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2013-06-25 | — | — | US | disclosed |
| EP-1944291-B1 | Optically active cyclic alcohol compound and method for producing same | MITSUBISHI TANABE PHARMA CORP (JP) | 2012-06-13 | — | — | EP | disclosed |
| EP-0748805-B1 | Naphthalene derivatives, process for the preparation thereof, and intermediates therefor, and pharmaceutical compositions comprising them | TANABE SEIYAKU CO (JP) | 1998-04-08 | — | — | EP | disclosed |
| EP-0748805-A1 | Naphthalene derivatives, process for the preparation thereof, and intermediates therefor, and pharmaceutical compositions comprising them | TANABE SEIYAKU CO., LTD. (JP) | 1996-12-18 | — | — | EP | disclosed |
| EP-0557016-B1 | Naphthalene derivatives, processes for preparing the same, and synthetic intermediates therefor | TANABE SEIYAKU CO (JP) | 1996-06-19 | — | — | EP | disclosed |
| US-5342941-A | Bronchodilating agents | TANABE SEIYAKU CO., LTD. (JP) | 1994-08-30 | — | — | US | disclosed |
| EP-0401125-B1 | Biphenyl derivatives, process for preparing the same and intermediates therefor | TANABE SEIYAKU CO (JP) | 1994-08-24 | — | — | EP | disclosed |
| EP-0557016-A1 | Naphthalene derivatives, processes for preparing the same, and synthetic intermediates therefor | TANABE SEIYAKU CO., LTD. (JP) | 1993-08-25 | — | — | EP | disclosed |
| US-5233057-A | For treatment or prophylaxis of liver disorders | TANABE SEIYAKU CO., LTD. (JP) | 1993-08-03 | — | — | US | disclosed |
| US-5182404-A | Liver disorders | TANABE SEIYAKE CO., LTD. (JP) | 1993-01-26 | — | — | US | disclosed |
| US-5103023-A | Carboxy derivates with oxy subsitituents for treating liuer disorders | TANABE SEIYAKU CO., LTD. (JP) | 1992-04-07 | — | — | US | disclosed |
| EP-0401125-A2 | Biphenyl derivatives, process for preparing the same and intermediates therefor | TANABE SEIYAKU CO., LTD. (JP) | 1990-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152082-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | HRH1, HRH4, RB1 | GAA 2968/4885PRKDC 251/4885POLB 494/4885 |
| US-20130237708-A1 | Optically Active Cyclic Alcohol Compound And Method For Preparing The Same | ADH1C, ADH1A, ADH5 | GAA 3418/4885PRKDC 1741/4885POLB 777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.